LIMNW

Investor Moves

Name	Value	Action	Change	Price	Current Price
Steven CohenPoint72 $-434 ExitQ1 2026 $434 -- $0.0967

Trade LIMNW

About Liminatus Pharma, Inc. Warrants

Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.

CEO: Chris Kim
IPO Date: Apr 30, 2025

Market Data

Open: $0.061
High: $0.061
Low: $0.061
Volume: 700
Avg Volume: 21.3K
52W High: $0.061
52W Low: $0.061

Valuation

Market Cap: $1.6M
Enterprise Value: $2.7M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-10.0M
Revenue: $0
Net Income: $-10M
Cash: $338k
Debt: $1.4M

Events

IPOApr 30

NASDAQ